Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab
Clinical trial NCT05602207 · COMPLETED
Trial details
- NCT number
- NCT05602207
- Sponsor
- Innovaderm Research Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-25
- Primary completion
- 2024-12-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.